|The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study|
M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ...
The Lancet Psychiatry 6 (5), 427-436, 2019
|Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study|
CJA Morgan, G Schafer, TP Freeman, HV Curran
The British Journal of Psychiatry 197 (4), 285-290, 2010
|Keep off the grass? Cannabis, cognition and addiction|
HV Curran, TP Freeman, C Mokrysz, DA Lewis, CJA Morgan, LH Parsons
Nature Reviews Neuroscience 17 (5), 293-306, 2016
|Examining the profile of high-potency cannabis and its association with severity of cannabis dependence|
TP Freeman, AR Winstock
Psychological medicine 45 (15), 3181-3189, 2015
|Cannabidiol attenuates the appetitive effects of Δ 9-tetrahydrocannabinol in humans smoking their chosen cannabis|
CJA Morgan, TP Freeman, GL Schafer, HV Curran
Neuropsychopharmacology 35 (9), 1879-1885, 2010
|New trends in cannabis potency in USA and Europe during the last decade (2008–2017)|
S Chandra, MM Radwan, CG Majumdar, JC Church, TP Freeman, ...
European archives of psychiatry and clinical neuroscience 269 (1), 5-15, 2019
|Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being|
CJA Morgan, C Gardener, G Schafer, S Swan, C Demarchi, TP Freeman, ...
Psychological medicine 42 (2), 391-400, 2012
|Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis …|
C Hindocha, TP Freeman, G Schafer, C Gardener, RK Das, CJA Morgan, ...
European Neuropsychopharmacology 25 (3), 325-334, 2015
|Can we make cannabis safer?|
A Englund, TP Freeman, RM Murray, P McGuire
The Lancet Psychiatry 4 (8), 643-648, 2017
|Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?|
TP Freeman, CJA Morgan, C Hindocha, G Schafer, RK Das, HV Curran
Addiction 109 (10), 1686-1694, 2014
|Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’|
TP Freeman, CJA Morgan, J Vaughn‐Jones, N Hussain, K Karimi, ...
Addiction 107 (4), 792-800, 2012
|The neuropsychopharmacology of cannabis: A review of human imaging studies|
MAP Bloomfield, C Hindocha, SF Green, MB Wall, R Lees, K Petrilli, ...
Pharmacology & therapeutics 195, 132-161, 2019
|Medicinal use of cannabis based products and cannabinoids|
TP Freeman, C Hindocha, SF Green, MAP Bloomfield
Bmj 365, 2019
|No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit|
C Hindocha, TP Freeman, JA Ferris, MT Lynskey, AR Winstock
Frontiers in psychiatry 7, 104, 2016
|Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’hypotheses|
W Lawn, TP Freeman, RA Pope, A Joye, L Harvey, C Hindocha, ...
Psychopharmacology 233 (19), 3537-3552, 2016
|Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom|
C Hindocha, NDC Shaban, TP Freeman, RK Das, G Gale, G Schafer, ...
Drug and alcohol dependence 148, 165-171, 2015
|Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands|
TP Freeman, P van der Pol, W Kuijpers, J Wisselink, RK Das, S Rigter, ...
Psychological medicine 48 (14), 2346-2352, 2018
|Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’and individually: a placebo-controlled trial|
C Hindocha, TP Freeman, JX Xia, NDC Shaban, HV Curran
Psychological Medicine 47 (15), 2708-2719, 2017
|How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review|
AM Freeman, K Petrilli, R Lees, C Hindocha, C Mokrysz, HV Curran, ...
Neuroscience & Biobehavioral Reviews 107, 696-712, 2019
|Increasing potency and price of cannabis in Europe, 2006–16|
TP Freeman, T Groshkova, A Cunningham, R Sedefov, P Griffiths, ...
Addiction 114 (6), 1015-1023, 2019